Electrophysiology Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Electrophysiology Devices Pipeline Market Report Overview

Electrophysiology equipment analyzes the electrical activity of the heart. The equipment is used with cardiac catheters and sophisticated computers to generate electrocardiogram (EKG) tracings and electrical measurements with exquisite precision from within the heart chambers. RF generators may be used in conjunction with electrophysiology equipment to treat the abnormal impulse generating areas in the heart.

The Electrophysiology Devices pipeline market research report provides comprehensive information about the Electrophysiology Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Electrophysiology Devices Pipeline Market Segments

Some of the key segments in the Electrophysiology Devices pipeline market are Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Advanced Ablation Catheters, Electrophysiology Lab Systems, Irrigated tip RF Ablation Catheters, Cryoablation Catheters, Intracardiac Echocardiography (ICE) Systems, 3D Mapping Systems, Conventional Radio Frequency Ablation Catheters, and Radiofrequency Ablation Generators. As of April 2023, Electrophysiology Ablation Catheters has the highest number of pipeline products.

Electrophysiology Devices Pipeline Market Analysis, by Segments, 2023 (%)

Electrophysiology Devices Pipeline Market Analysis, by Segments, 2023 (%)

For more segment insights into the Electrophysiology Devices pipeline market, download a free report sample

Electrophysiology Devices Pipeline Market Segmentation by Territories

Some of the key territories in the Electrophysiology Devices pipeline market are the US, China, Europe, Japan, Australia, Israel, Russia, Canada, Macau, and New Zealand. As of April 2023, the US has the highest number of products.

Electrophysiology Devices Pipeline Market Analysis, by Territories, 2023 (%)

Electrophysiology Devices Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the Electrophysiology Devices pipeline market, download a free report sample

Electrophysiology Devices Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the Electrophysiology Devices pipeline market are 510(k), NMPA, CE, PMA, TGA, Shonin, Ninsho, MDL, and MDCO. As of April 2023, 510(k) is the most followed pathway for the pipeline products.

Electrophysiology Devices Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Electrophysiology Devices Pipeline Market Analysis, by Territories, 2023 (%)

For more regulatory path insights into the Electrophysiology Devices pipeline market, download a free report sample

Electrophysiology Devices Pipeline Market – Competitive Landscape

Some of the key companies in the Electrophysiology Devices pipeline market are Ablacon Inc, AccuPulse Medical Technology Co Ltd, Acotec Scientific Co Ltd, Acutus Medical Inc, Apama Medical Inc, APT Medical Inc, AtriCure Inc, Aust Development, LLC, Baylor College of Medicine, and Ben-Gurion University of the Negev.

Ablacon Inc: Ablacon Inc offers AI based atrial fibrillation therapies that visualizes electrographic flow and monitors heart in real time to qualitatively and quantitatively understand and treat atrial fibrillation (AF).

Acutus Medical Inc: Headquartered in Carlsbad, California, the US, Acutus Medical Inc (Acutus Medical) is engaged in providing electrophysiological mapping systems for the treatment of cardiac arrhythmias. It offers various products which include AcQMap system, AcQMap 3D imaging and mapping catheterand AcQGuide steerable sheath. Acutus Medical’s electrofunctional mapping systems provides solutions to diagnose and treat atrial fibrillation. The company products enable physicians to visualize CT-quality scan, map real-time dipole density, and identify infected locations causing arrhythmia.

Electrophysiology Devices Pipeline Market Report Overview

Key Territories The US, China, Europe, Japan, Australia,               Israel, Russia, Canada, Macau, and New Zealand
Key Segments Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Advanced Ablation Catheters, Electrophysiology Lab Systems, Irrigated tip RF Ablation Catheters, Cryoablation Catheters, Intracardiac Echocardiography (ICE) Systems, 3D Mapping Systems, Conventional Radio Frequency Ablation Catheters, and Radiofrequency Ablation Generators
Key Regulatory Paths 510(k), NMPA, CE, PMA, TGA, Shonin, Ninsho, MDL, and MDCO

 

Leading Companies Ablacon Inc, AccuPulse Medical Technology Co Ltd, Acotec Scientific Co Ltd, Acutus Medical Inc, Apama Medical Inc, APT Medical Inc, AtriCure Inc, Aust Development, LLC, Baylor College of Medicine, and Ben-Gurion University of the Negev

Segments Covered in the Report

  • Electrophysiology Devices Pipeline Market Segments Outlook
  • Electrophysiology Ablation Catheters
  • Electrophysiology Diagnostic Catheters
  • Advanced Ablation Catheters
  • Electrophysiology Lab Systems
  • Irrigated tip RF Ablation Catheters
  • Cryoablation Catheters
  • Intracardiac Echocardiography (ICE) Systems
  • 3D Mapping Systems
  • Conventional Radio Frequency Ablation Catheters
  • Radiofrequency Ablation Generators
  • Laser Ablation Catheters
  • Steerable Diagnostic Catheters
  • Ultrasound Diagnostic Catheters
  • Standard Ablation Catheters
  • Cardiac Stimulators

Electrophysiology Devices Pipeline Market Territories Outlook

  • The US
  • China
  • Europe
  • Japan
  • Australia
  • Israel
  • Russia
  • Canada
  • Macau
  • New Zealand
  • Hong Kong
  • Thailand

Electrophysiology Devices Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • NMPA
  • CE
  • PMA
  • TGA
  • Shonin
  • Ninsho
  • MDL
  • MDCO

Scope

  • Extensive coverage of the Electrophysiology Devices under development
  • Reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • Reviews the major players involved in the development of Electrophysiology Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • Provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Electrophysiology Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Ablacon Inc
AccuPulse Medical Technology Co Ltd
Acotec Scientific Co Ltd
Acutus Medical Inc
Apama Medical Inc
APT Medical Inc
AtriCure Inc
Aust Development, LLC
Baylor College of Medicine
Ben-Gurion University of the Negev
Berlin Heals GmbH
Biosense Webster Inc
BioSig Technologies Inc
BioTex Inc
Biotronik AG
Biotronik Australia Pty Ltd
Biotronik SE & Co KG
Boston Scientific Corp
Cardima, Inc. (Inactive)
CardioFocus Inc
CardioNova Ltd
CathEffects LLC
catheter precision Inc
CathRx Ltd
CathVision Aps
Cibiem, Inc.
ClearPoint Neuro Inc
Columbia University
Conavi Medical Inc
Cordis Corp
CoreMap Inc
CoRepair, Inc
Corify Care SL
CryoTherapeutics Gmbh
CyberHeart Inc
EPD Solutions Ltd
Epicardial Technologies Inc (Inactive)
EPMap-System GmbH & Co KG
Ethicon US LLC
Eximo Medical Ltd
Farapulse Inc
FocusStart LLC
Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon
Galvanize Therapeutics Inc
Hansen Medical Inc (Inactive)
Hyblate Medical
Imricor Medical Systems Inc
Interventional Imaging, Inc.
Iowa Approach Inc.
Japan Lifeline Co Ltd
Jiangsu Tingsheng Technology Co Ltd
Johns Hopkins University
King's College London
Koninklijke Philips NV
Lepu Medical Technology (Beijing) Co Ltd
Lepu Scientech Medical Technology (Shanghai) Co Ltd
Maestro Heart SA
MC10 Inc
Medlumics SL
Medtronic Plc
MedWaves Inc
Medyria AG
MicroPort NeuroTech Ltd
MicroPort Scientific Corp
NeuTrace Inc
Northwestern University
Novasentis Inc
OrbusNeich
Philips Healthcare
S4 Medical Corp
SCR, Inc.
Seattle Children's Hospital
Seoul National University Hospital
Shanghai HeartCare Medical Technology Co Ltd
Shanghai MicroPort EP MedTech Co Ltd
ST Cardio Technologies LLC
St. Jude Medical LLC
Stanford University
Stereotaxis Inc
Suzhou Aikemai Medical Technology Co Ltd
Suzhou Bingjing Intelligent Medical Technology Co Ltd
Suzhou Hengruihongyuan Medical Technology Co Ltd
Suzhou Xinmai Medical Equipment Co Ltd
The Cleveland Clinic Foundation
University of Arkansas at Little Rock
University of Auckland
University of Maryland
University of Michigan
University of Rochester
University of Texas Medical Branch at Galveston
University of Utah
Vanderbilt University
Vimecon GmbH
Viscardia Inc
Vivonics Inc
Voyage Medical (Inactive)
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 8

|1.2 List of Figures 18

2 Introduction 19

2.1 Electrophysiology Devices Overview 19

3 Products under Development 21

3.1 Electrophysiology Devices – Pipeline Products by Stage of Development 21

3.2 Electrophysiology Devices – Pipeline Products by Segment 22

3.3 Electrophysiology Devices – Pipeline Products by Territory 23

3.4 Electrophysiology Devices – Pipeline Products by Regulatory Path 24

3.5 Electrophysiology Devices – Pipeline Products by Estimated Approval Date 25

3.6 Electrophysiology Devices – Ongoing Clinical Trials 26

4 Electrophysiology Devices – Pipeline Products under Development by Companies 27

4.1 Electrophysiology Devices Companies – Pipeline Products by Stage of Development 27

4.2 Electrophysiology Devices – Pipeline Products by Stage of Development 31

5 Electrophysiology Devices Companies and Product Overview 36

5.1 Ablacon Inc Company Overview 36

5.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.2 AccuPulse Medical Technology Co Ltd Company Overview 40

5.2.1 AccuPulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.3 Acotec Scientific Co Ltd Company Overview 41

5.3.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

5.4 Acutus Medical Inc Company Overview 44

5.4.1 Acutus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.5 Apama Medical Inc Company Overview 49

5.5.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.6 APT Medical Inc Company Overview 50

5.6.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.7 AtriCure Inc Company Overview 56

5.7.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.8 Aust Development, LLC Company Overview 57

5.8.1 Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 57

5.9 Baylor College of Medicine Company Overview 58

5.9.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 58

5.10 Ben-Gurion University of the Negev Company Overview 59

5.10.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 59

5.11 Berlin Heals GmbH Company Overview 60

5.11.1 Berlin Heals GmbH Pipeline Products & Ongoing Clinical Trials Overview 60

5.12 Biosense Webster Inc Company Overview 63

5.12.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.13 BioSig Technologies Inc Company Overview 73

5.13.1 BioSig Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.14 BioTex Inc Company Overview 78

5.14.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.15 Biotronik AG Company Overview 79

5.15.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview 79

5.16 Biotronik Australia Pty Ltd Company Overview 83

5.16.1 Biotronik Australia Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 83

5.17 Biotronik SE & Co KG Company Overview 86

5.17.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 86

5.18 Boston Scientific Corp Company Overview 87

5.18.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 87

5.19 Cardima, Inc. (Inactive) Company Overview 97

5.19.1 Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 97

5.20 CardioFocus Inc Company Overview 99

5.20.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 99

5.21 CardioNova Ltd Company Overview 102

5.21.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 102

5.22 CathEffects LLC Company Overview 103

5.22.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 103

5.23 catheter precision Inc Company Overview 104

5.23.1 catheter precision Inc Pipeline Products & Ongoing Clinical Trials Overview 104

5.24 CathRx Ltd Company Overview 105

5.24.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

5.25 CathVision Aps Company Overview 108

5.25.1 CathVision Aps Pipeline Products & Ongoing Clinical Trials Overview 108

5.26 Cibiem, Inc. Company Overview 111

5.26.1 Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111

5.27 ClearPoint Neuro Inc Company Overview 112

5.27.1 ClearPoint Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview 112

5.28 Columbia University Company Overview 114

5.28.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 114

5.29 Conavi Medical Inc Company Overview 115

5.29.1 Conavi Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 115

5.30 Cordis Corp Company Overview 118

5.30.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 118

5.31 CoreMap Inc Company Overview 120

5.31.1 CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview 120

5.32 CoRepair, Inc Company Overview 121

5.32.1 CoRepair, Inc Pipeline Products & Ongoing Clinical Trials Overview 121

5.33 Corify Care SL Company Overview 122

5.33.1 Corify Care SL Pipeline Products & Ongoing Clinical Trials Overview 122

5.34 CryoTherapeutics Gmbh Company Overview 125

5.34.1 CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 125

5.35 CyberHeart Inc Company Overview 128

5.35.1 CyberHeart Inc Pipeline Products & Ongoing Clinical Trials Overview 128

5.36 EPD Solutions Ltd Company Overview 131

5.36.1 EPD Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 131

5.37 Epicardial Technologies Inc (Inactive) Company Overview 134

5.37.1 Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 134

5.38 EPMap-System GmbH & Co KG Company Overview 135

5.38.1 EPMap-System GmbH & Co KG Pipeline Products & Ongoing Clinical Trials Overview 135

5.39 Ethicon US LLC Company Overview 137

5.39.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 137

5.40 Eximo Medical Ltd Company Overview 138

5.40.1 Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 138

5.41 Farapulse Inc Company Overview 139

5.41.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview 139

5.42 FocusStart LLC Company Overview 142

5.42.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 142

5.43 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 143

5.43.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 143

5.44 Galvanize Therapeutics Inc Company Overview 144

5.44.1 Galvanize Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 144

5.45 Hansen Medical Inc (Inactive) Company Overview 147

5.45.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 147

5.46 Hyblate Medical Company Overview 149

5.46.1 Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview 149

5.47 Imricor Medical Systems Inc Company Overview 150

5.47.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 150

5.48 Interventional Imaging, Inc. Company Overview 156

5.48.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 156

5.49 Iowa Approach Inc. Company Overview 157

5.49.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 157

5.50 Japan Lifeline Co Ltd Company Overview 160

5.50.1 Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 160

5.51 Jiangsu Tingsheng Technology Co Ltd Company Overview 162

5.51.1 Jiangsu Tingsheng Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 162

5.52 Johns Hopkins University Company Overview 165

5.52.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 165

5.53 King’s College London Company Overview 166

5.53.1 King’s College London Pipeline Products & Ongoing Clinical Trials Overview 166

5.54 Koninklijke Philips NV Company Overview 167

5.54.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 167

5.55 Lepu Medical Technology (Beijing) Co Ltd Company Overview 168

5.55.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 168

5.56 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview 169

5.56.1 Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 169

5.57 Maestro Heart SA Company Overview 170

5.57.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 170

5.58 MC10 Inc Company Overview 171

5.58.1 MC10 Inc Pipeline Products & Ongoing Clinical Trials Overview 171

5.59 Medlumics SL Company Overview 172

5.59.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 172

5.60 Medtronic Plc Company Overview 173

5.60.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 173

5.61 MedWaves Inc Company Overview 179

5.61.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 179

5.62 Medyria AG Company Overview 180

5.62.1 Medyria AG Pipeline Products & Ongoing Clinical Trials Overview 180

5.63 MicroPort NeuroTech Ltd Company Overview 181

5.63.1 MicroPort NeuroTech Ltd Pipeline Products & Ongoing Clinical Trials Overview 181

5.64 MicroPort Scientific Corp Company Overview 182

5.64.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 182

5.65 NeuTrace Inc Company Overview 185

5.65.1 NeuTrace Inc Pipeline Products & Ongoing Clinical Trials Overview 185

5.66 Northwestern University Company Overview 188

5.66.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 188

5.67 Novasentis Inc Company Overview 189

5.67.1 Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview 189

5.68 OrbusNeich Company Overview 190

5.68.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 190

5.69 Philips Healthcare Company Overview 192

5.69.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 192

5.70 S4 Medical Corp Company Overview 193

5.70.1 S4 Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 193

5.71 SCR, Inc. Company Overview 194

5.71.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 194

5.72 Seattle Children’s Hospital Company Overview 195

5.72.1 Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 195

5.73 Seoul National University Hospital Company Overview 196

5.73.1 Seoul National University Hospital Pipeline Products & Ongoing Clinical Trials Overview 196

5.74 Shanghai HeartCare Medical Technology Co Ltd Company Overview 197

5.74.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 197

5.75 Shanghai MicroPort EP MedTech Co Ltd Company Overview 198

5.75.1 Shanghai MicroPort EP MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 198

5.76 ST Cardio Technologies LLC Company Overview 203

5.76.1 ST Cardio Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 203

5.77 St. Jude Medical LLC Company Overview 204

5.77.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 204

5.78 Stanford University Company Overview 208

5.78.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 208

5.79 Stereotaxis Inc Company Overview 209

5.79.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 209

5.80 Suzhou Aikemai Medical Technology Co Ltd Company Overview 212

5.80.1 Suzhou Aikemai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 212

5.81 Suzhou Bingjing Intelligent Medical Technology Co Ltd Company Overview 213

5.81.1 Suzhou Bingjing Intelligent Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 213

5.82 Suzhou Hengruihongyuan Medical Technology Co Ltd Company Overview 216

5.82.1 Suzhou Hengruihongyuan Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 216

5.83 Suzhou Xinmai Medical Equipment Co Ltd Company Overview 219

5.83.1 Suzhou Xinmai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 219

5.84 The Cleveland Clinic Foundation Company Overview 220

5.84.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 220

5.85 University of Arkansas at Little Rock Company Overview 221

5.85.1 University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview 221

5.86 University of Auckland Company Overview 222

5.86.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 222

5.87 University of Maryland Company Overview 223

5.87.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 223

5.88 University of Michigan Company Overview 224

5.88.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 224

5.89 University of Rochester Company Overview 225

5.89.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 225

5.90 University of Texas Medical Branch at Galveston Company Overview 226

5.90.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 226

5.91 University of Utah Company Overview 227

5.91.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 227

5.92 Vanderbilt University Company Overview 228

5.92.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 228

5.93 Vimecon GmbH Company Overview 229

5.93.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 229

5.94 Viscardia Inc Company Overview 230

5.94.1 Viscardia Inc Pipeline Products & Ongoing Clinical Trials Overview 230

5.95 Vivonics Inc Company Overview 233

5.95.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 233

5.96 Voyage Medical (Inactive) Company Overview 234

5.96.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 234

5.97 Zylox-Tonbridge Medical Technology Co Ltd Company Overview 235

5.97.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 235

6 Electrophysiology Devices- Recent Developments 236

6.1 Apr 12, 2023: Medtronic has a layoff in California 236

6.2 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023 236

6.3 Mar 30, 2023: Integer Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 236

6.4 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 237

6.5 Mar 02, 2023: Researchers suggest novel cutpoints for diagnosing cardiac hypertrophy in adolescents and young adults 237

6.6 Feb 23, 2023: Us2.ai to deliver AI-enabled echocardiography decision support to Brigham and Women’s Hospital’s Cardiac Imaging Core Laboratory 238

6.7 Feb 16, 2023: Integer Holdings Reports Results for Fourth Quarter and Full Year 2022 238

6.8 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023 241

6.9 Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022 241

6.10 Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results 242

6.11 Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023 245

6.12 Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook 245

6.13 Jan 05, 2023: GE HealthCare appoints former Amazon exec as first chief technology officer 246

6.14 Dec 20, 2022: AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference 246

6.15 Nov 23, 2022: Medtronic Reports Quarterly Earnings 246

6.16 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 246

6.17 Nov 22, 2022: Mayo Clinic surgeon takes the wheel as Kwik Trip’s new CEO 252

6.18 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 252

6.19 Nov 07, 2022: OxSonics Therapeutics announces Jerome Marzinski Appointed as Chief Executive Officer 252

6.20 Nov 07, 2022: National study suggests it’s time to rethink how we treat atrial fibrillation 253

6.21 Oct 27, 2022: Integer Holdings Reports Third Quarter 2022 Results 254

6.22 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022 255

6.23 Oct 11, 2022: AtriCure to Announce Third Quarter 2022 Financial Results 256

6.24 Sep 30, 2022: Natalie Caine named chief administrative officer at Mayo Clinic in Rochester 256

6.25 Sep 27, 2022: Catheter Precision names Fatih Ayoglu as Business Development Manager—EMEA 256

6.26 Sep 23, 2022: Mentice receives an order of USD 620,000 for simulation solutions and development services 257

6.27 Sep 07, 2022: Medtronic to appear at September investor conferences 257

6.28 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 257

6.29 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 260

6.30 Aug 16, 2022: AtriCure to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference 263

6.31 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule 263

6.32 Aug 08, 2022: ClearPoint Neuro Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs 263

6.33 Aug 03, 2022: Harvard Bioscience Announces Second Quarter 2022 Financial Results 264

6.34 Aug 02, 2022: AtriCure Reports Second Quarter 2022 Financial Results 264

6.35 Jul 28, 2022: Integer Holdings Reports Second Quarter 2022 Results 265

6.36 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022 266

6.37 Jul 20, 2022: AtriCure to Participate at Upcoming Investor Conferences 267

6.38 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022 268

6.39 Jul 12, 2022: AtriCure to Announce Second Quarter 2022 Financial Results 268

6.40 Jul 08, 2022: Cordis Names Bryan Loo President of Asia-pacific Region 268

6.41 Jun 28, 2022: Japan Lifeline Co. Notice of Resolution of the 42nd Annual General Meeting of Shareholders 269

6.42 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 270

6.43 Jun 23, 2022: Cleveland Clinic Appoints Alex A. Adjei, M.D., Ph.D., as Chair of Taussig Cancer Institute 270

6.44 Jun 01, 2022: AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer 271

6.45 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 272

6.46 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 272

6.47 May 10, 2022: Stereotaxis Reports 2022 First Quarter Financial Results 272

6.48 May 04, 2022: Harvard Bioscience Announces First Quarter 2022 Financial Results 273

7 Appendix 275

7.1 Methodology 275

7.2 About GlobalData 278

7.3 Contact Us 278

7.4 Disclaimer 278

Frequently asked questions

Electrophysiology Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Electrophysiology Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Electrophysiology Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Electrophysiology Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.